These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18001616)

  • 41. Stroke prevention, blood cholesterol and statins.
    Amarenco P; Lavallée PC; Labreuche J; Touboul PJ
    Acta Neurol Taiwan; 2005 Sep; 14(3):96-112. PubMed ID: 16252611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Goldstein LB; Amarenco P; Zivin J; Messig M; Altafullah I; Callahan A; Hennerici M; MacLeod MJ; Sillesen H; Zweifler R; Michael K; Welch A;
    Stroke; 2009 Nov; 40(11):3526-31. PubMed ID: 19745172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atorvastatin and cardiovascular risk in the elderly--patient considerations.
    Acharjee S; Welty FK
    Clin Interv Aging; 2008; 3(2):299-314. PubMed ID: 18686752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K.
    Sever PS; Chang CL; Gupta AK; Whitehouse A; Poulter NR;
    Eur Heart J; 2011 Oct; 32(20):2525-32. PubMed ID: 21873710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Schwartz GG; Chaitman BR; Goldberger JJ; Messig M
    Am Heart J; 2011 May; 161(5):993-9. PubMed ID: 21570534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes.
    Chan KE; Thadhani R; Lazarus JM; Hakim RM
    Clin J Am Soc Nephrol; 2010 May; 5(5):856-66. PubMed ID: 20338963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrovascular disease and statins: a potential addition to the therapeutic armamentarium for stroke prevention.
    Callahan A
    Am J Cardiol; 2001 Oct; 88(7B):33J-37J. PubMed ID: 11595197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
    LaRosa JC; Grundy SM; Waters DD; Shear C; Barter P; Fruchart JC; Gotto AM; Greten H; Kastelein JJ; Shepherd J; Wenger NK;
    N Engl J Med; 2005 Apr; 352(14):1425-35. PubMed ID: 15755765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
    Saw J; Steinhubl SR; Berger PB; Kereiakes DJ; Serebruany VL; Brennan D; Topol EJ;
    Circulation; 2003 Aug; 108(8):921-4. PubMed ID: 12925453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C-reactive protein levels and outcomes after statin therapy.
    Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E;
    N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
    Corvol JC; Bouzamondo A; Sirol M; Hulot JS; Sanchez P; Lechat P
    Arch Intern Med; 2003 Mar; 163(6):669-76. PubMed ID: 12639199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The collaborative atorvastatin diabetes study: preliminary results.
    Owen OG
    Int J Clin Pract; 2005 Jan; 59(1):121-3. PubMed ID: 15707477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences between statins on clinical endpoints: a population-based cohort study.
    Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC
    Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials.
    Hsue PY; Bittner VA; Betteridge J; Fayyad R; Laskey R; Wenger NK; Waters DD
    Am J Cardiol; 2015 Feb; 115(4):447-53. PubMed ID: 25637322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of statins in stroke prevention.
    Amarenco P
    Curr Opin Lipidol; 2005 Dec; 16(6):614-8. PubMed ID: 16276237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology.
    Ray KK; Cannon CP
    Curr Opin Lipidol; 2004 Dec; 15(6):637-43. PubMed ID: 15529022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study.
    Kashima Y; Izawa A; Aizawa K; Koshikawa M; Kasai H; Tomita T; Kumazaki S; Tsutsui H; Koyama J; Ikeda U
    J Cardiol; 2009 Aug; 54(1):76-9. PubMed ID: 19632524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statins and stroke: current clinical practice.
    Castilla-Guerra L; Espino-Montoro A; Fernandez Moreno Mdel C; López-Chozas JM; Jimérnez MD
    Stroke; 2006 May; 37(5):1153. PubMed ID: 16556875
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute statin treatment in reducing risk after acute coronary syndrome: the MIRACL (Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering) Trial.
    Ahsan CH; Shah A; Ezekowitz M
    Curr Opin Cardiol; 2001 Nov; 16(6):390-3. PubMed ID: 11704711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
    Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
    Lancet; 2003 Apr; 361(9364):1149-58. PubMed ID: 12686036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.